A two-site sandwich radioimmunoassay of human gamma interferon with monoclonal antibodies. 1985

E Tanaka, and M Imai, and S Usuda, and K Tachibana, and H Okamoto, and Y Ohike, and T Nakamura, and Y Miyakawa, and M Mayumi

Two monoclonal antibodies (nos. 6008 and 6016) were raised against human gamma interferon (IFN-gamma) derived from E. coli harboring the recombinant cDNA for IFN-gamma, and one (3710) against a synthetic peptide representing its C-terminus amino acid sequence of 20 residues. The monoclonal antibody against the synthetic peptide (3710) reacted either with IFN-gamma or the synthetic peptide. One monoclonal anti-IFN-gamma (6008) did not react with the synthetic peptide, while the other (6016) showed a weak binding with the peptide. The binding of the monoclonal antibody against the synthetic peptide (3710) with IFN-gamma was not inhibited by 6008, but to a certain extent by 6016. A 2-site '1-step' radioimmunoassay was developed in which 6008 was fixed on a solid-phase support, and the test sample together with radiolabeled 3710 was added for the binding with it. The assay was rapid with a sensitivity capable of detecting a few ng/ml of IFN-gamma.

UI MeSH Term Description Entries
D007371 Interferon-gamma The major interferon produced by mitogenically or antigenically stimulated LYMPHOCYTES. It is structurally different from TYPE I INTERFERON and its major activity is immunoregulation. It has been implicated in the expression of CLASS II HISTOCOMPATIBILITY ANTIGENS in cells that do not normally produce them, leading to AUTOIMMUNE DISEASES. Interferon Type II,Interferon, Immune,gamma-Interferon,Interferon, gamma,Type II Interferon,Immune Interferon,Interferon, Type II
D010446 Peptide Fragments Partial proteins formed by partial hydrolysis of complete proteins or generated through PROTEIN ENGINEERING techniques. Peptide Fragment,Fragment, Peptide,Fragments, Peptide
D011863 Radioimmunoassay Classic quantitative assay for detection of antigen-antibody reactions using a radioactively labeled substance (radioligand) either directly or indirectly to measure the binding of the unlabeled substance to a specific antibody or other receptor system. Non-immunogenic substances (e.g., haptens) can be measured if coupled to larger carrier proteins (e.g., bovine gamma-globulin or human serum albumin) capable of inducing antibody formation. Radioimmunoassays
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000911 Antibodies, Monoclonal Antibodies produced by a single clone of cells. Monoclonal Antibodies,Monoclonal Antibody,Antibody, Monoclonal
D000918 Antibody Specificity The property of antibodies which enables them to react with some ANTIGENIC DETERMINANTS and not with others. Specificity is dependent on chemical composition, physical forces, and molecular structure at the binding site. Antibody Specificities,Specificities, Antibody,Specificity, Antibody

Related Publications

E Tanaka, and M Imai, and S Usuda, and K Tachibana, and H Okamoto, and Y Ohike, and T Nakamura, and Y Miyakawa, and M Mayumi
November 1988, Japanese circulation journal,
E Tanaka, and M Imai, and S Usuda, and K Tachibana, and H Okamoto, and Y Ohike, and T Nakamura, and Y Miyakawa, and M Mayumi
November 1984, Journal of immunological methods,
E Tanaka, and M Imai, and S Usuda, and K Tachibana, and H Okamoto, and Y Ohike, and T Nakamura, and Y Miyakawa, and M Mayumi
March 1983, Journal of immunological methods,
E Tanaka, and M Imai, and S Usuda, and K Tachibana, and H Okamoto, and Y Ohike, and T Nakamura, and Y Miyakawa, and M Mayumi
October 1985, Journal of immunological methods,
E Tanaka, and M Imai, and S Usuda, and K Tachibana, and H Okamoto, and Y Ohike, and T Nakamura, and Y Miyakawa, and M Mayumi
January 1983, The EMBO journal,
E Tanaka, and M Imai, and S Usuda, and K Tachibana, and H Okamoto, and Y Ohike, and T Nakamura, and Y Miyakawa, and M Mayumi
January 1981, Journal of immunological methods,
E Tanaka, and M Imai, and S Usuda, and K Tachibana, and H Okamoto, and Y Ohike, and T Nakamura, and Y Miyakawa, and M Mayumi
November 1987, Journal of immunological methods,
E Tanaka, and M Imai, and S Usuda, and K Tachibana, and H Okamoto, and Y Ohike, and T Nakamura, and Y Miyakawa, and M Mayumi
March 1982, Molecular immunology,
E Tanaka, and M Imai, and S Usuda, and K Tachibana, and H Okamoto, and Y Ohike, and T Nakamura, and Y Miyakawa, and M Mayumi
January 1986, Methods in enzymology,
E Tanaka, and M Imai, and S Usuda, and K Tachibana, and H Okamoto, and Y Ohike, and T Nakamura, and Y Miyakawa, and M Mayumi
April 1987, Hybridoma,
Copied contents to your clipboard!